Amgen, Biogen news

AMGN General Counsel Tom Workman said in a statement that the company is "confident that the making, using or selling of our Neupogen G-CSF does not infringe any valid, enforceable claim of the Biogen patent."

BioGenex Laboratories

BioTek Solutions Inc.

BioGenex (San

Read the full 428 word article

How to gain access

Continue reading with a
two-week free trial.